AstraZeneca says COVID-19 vaccine trial in U.S still on hold

(Reuters) – AstraZeneca Plc said on Saturday that its COVID-19 vaccine trial in the United States is still on hold.

AstraZeneca on Saturday published a document https://bit.ly/2FNcqu7 describing details of how the COVID-19 vaccine trial was being carried out, which was first reported by the New York Times.

(Reporting by Rama Venkat in Bengaluru; Editing by Michael Perry)